glycine and Complex Regional Pain Syndrome studies

glycine and Complex Regional Pain Syndrome

Research Excerpts

Excerpt	Relevance	Reference
"Since glycinergic neurotransmission plays an important inhibitory role in the processing of sensory and motor information, intrathecal glycine (ITG) administration may be a potential therapy for both pain and movement disorders in patients with complex regional pain syndrome (CRPS)."	9.14	Intrathecal glycine for pain and dystonia in complex regional pain syndrome. ( Marinus, J; Munts, AG; Onkenhout, W; Teepe-Twiss, IM; van der Plas, AA; van Gerven, JM; van Hilten, JJ; Voormolen, JH, 2009)
"Since glycinergic neurotransmission plays an important inhibitory role in the processing of sensory and motor information, intrathecal glycine (ITG) administration may be a potential therapy for both pain and movement disorders in patients with complex regional pain syndrome (CRPS)."	5.14	Intrathecal glycine for pain and dystonia in complex regional pain syndrome. ( Marinus, J; Munts, AG; Onkenhout, W; Teepe-Twiss, IM; van der Plas, AA; van Gerven, JM; van Hilten, JJ; Voormolen, JH, 2009)

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

1 (100.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Munts, AG	1
van der Plas, AA	1
Voormolen, JH	1
Marinus, J	1
Teepe-Twiss, IM	1
Onkenhout, W	1
van Gerven, JM	1
van Hilten, JJ	1

Studies

Munts, AG

van der Plas, AA

Voormolen, JH

Marinus, J

Teepe-Twiss, IM

Onkenhout, W

van Gerven, JM

van Hilten, JJ

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Intrathecal Immunoglobulin for Treatment of Adult Patients With Tetanus: a Randomized Controlled 2x2 Factorial Trial[NCT02999815]	Phase 1/Phase 2	272 participants (Actual)	Interventional	2017-02-13	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Intrathecal Immunoglobulin for Treatment of Adult Patients With Tetanus: a Randomized Controlled 2x2 Factorial Trial[NCT02999815]

Phase 1/Phase 2

272 participants (Actual)

Interventional

2017-02-13

Completed

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for glycine and Complex Regional Pain Syndrome

Article	Year
Intrathecal glycine for pain and dystonia in complex regional pain syndrome. Pain, 2009, Volume: 146, Issue:1-2 Topics: Adult; Complex Regional Pain Syndromes; Cross-Over Studies; Double-Blind Method; Dystonia; Female; G	2009

Article

Year

Intrathecal glycine for pain and dystonia in complex regional pain syndrome.

Pain, 2009, Volume: 146, Issue:1-2

Topics: Adult; Complex Regional Pain Syndromes; Cross-Over Studies; Double-Blind Method; Dystonia; Female; G

2009